Hosted by the Ministry of Science and Technology and the Shenzhen Municipal People's Government, the China International Talent Exchange Conference – Shenzhen Forum was held at the Shenzhen Convention and Exhibition Center. Numerous experts, scholars, and business elites from home and abroad gathered for a top-level forum on technological innovation and talent development.
Dr. Hu Xiang of Beike Biotech delivered an invited keynote address
— "Technological Innovation Driving the Medical Revolution"
On April 14, 2019, the 17th China International Talent Exchange Conference – Shenzhen Forum, hosted by the Ministry of Science and Technology (State Administration of Foreign Experts Affairs) and the Shenzhen Municipal People's Government, was held at the Shenzhen Convention and Exhibition Center. Zhang Jianguo, Vice Minister of Science and Technology and Director of the State Administration of Foreign Experts Affairs; Liu Qingsheng, Standing Committee member of the Shenzhen Municipal Party Committee, Vice Mayor of the Shenzhen Municipal People's Government, and Secretary of its Party Leadership Group; and more than 700 experts, scholars, entrepreneurs, and business elites from home and abroad gathered to share, around such themes as "technological innovation" and "talent growth", their insights into the sustainable development and innovation of science, technology, and talent under new international circumstances.[1]
As a notable contributor to stem cell research and clinical translational application, Dr. Hu Xiang, Chairman of Beike Biotech, was invited to attend this forum and delivered an outstanding keynote address titled "Technological Innovation Driving the Medical Revolution". Around the three core themes of "people", "technology", and "life", he provided an in-depth interpretation of frontier areas such as life sciences and the biopharmaceutical industry, and shared his outlook on the future direction of medicine.
(Dr. Hu Xiang, Chairman of Beike Biotech, delivers a keynote address in the forum's "Building Core Competitiveness through Technological Innovation" segment)
Highlights from Dr. Hu Xiang's address at the forum:
Dr. Hu Xiang's outstanding presentation gave the audience a vivid sense of the appeal of biotechnology and instilled confidence in the future development of biopharmaceuticals and cell therapy.
Other distinguished speakers at the forum included Royal Academy of Engineering Fellows Sir Jim McDonald and John Speakman, the "Father of the Internet of Things" Kevin Ashton, Hong Kong Affairs Chief Liaison Officer of the Qianhai Authority Witman Hung, and University of Westminster Vice-Chancellor Peter Bonfield, all of whom delivered excellent presentations.
— Beike Biotech —
Founded in July 2005, Beike Biotech is one of China's earliest national high-tech enterprises specializing in the clinical translation and technical services of biotherapy technologies in the strategic emerging industries.
Beike Biotech has focused on the cell field for fourteen years and has a leading R&D team in the field. To date it has filed 82 patent applications in cell technology, 33 of which have been granted; published more than 100 papers in domestic and international journals, including authoritative journals such as Cell Stem Cell; and undertaken more than 60 government projects at all levels, including 6 national-level projects (2 of which are 863 Program projects).
In December 2015, the National Development and Reform Commission approved Beike Biotech to undertake the construction of the "National and Local Joint Engineering Laboratory for Personalized Cell Therapy Technology", which is a national-level technology development and translation platform driving the clinical translation of personalized cell therapy technologies in China.
